ALS Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
This funding opportunity is intended to support scientific research utilizing data from expanded access for investigational drugs or biological products as described in section 561 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb). These applications will target intermediate size populations of people living with ALS who are not eligible for ongoing clinical trials.
Last confirmed Oct 6, 2026 · Funder website
ALS Intermediate Patient Population Expanded Access (U01 Clinical Trial Required): Eligibility, Deadline, and Award Questions
Who is eligible for ALS Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)?
ALS Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) eligibility includes eligible applicants named in the notice. Geographic eligibility is FL and VA; applicants should confirm the source notice before applying.
What is the deadline for ALS Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)?
ALS Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) has a listed deadline of November 10, 2026. Grant deadlines can change, so verify the current date with AMYOTROPHIC LATERAL SCLEROSIS before submitting.
How much funding is available for ALS Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)?
ALS Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) lists an award size of not disclosed to $40M. Award ranges and total program funding are reported from the source metadata when available.
Who funds ALS Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)?
ALS Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) is funded by AMYOTROPHIC LATERAL SCLEROSIS. GrantSonar tracks the notice with source ID 943124732:als-intermediate-patient-population-expanded-access-u01-clinical-trial-required from funder_site.
Eligibility facets
Not listed in source metadata.
FL, VA
$0 to $40M
Funder website · 943124732:als-intermediate-patient-population-expanded-access-u01-clinical-trial-required
Check whether this grant fits your organization
GrantSonar compares the notice against your mission, geography, eligibility, and programs before you spend time writing.